Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CCKB antagonists(Cholecystokinin B receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC30H32N6O5 |
InChIKeyGPEYTRIZYSZRRK-MHZLTWQESA-N |
CAS Registry1801749-44-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Helicobacter Infections | Phase 2 | GB | - | |
Gastroesophageal Reflux | Phase 1 | GB | - | |
Neuroendocrine Tumors | Phase 1 | GB | - |